IIM
RNAC icon

Ironwood Investment Management’s Cartesian Therapeutics RNAC Stock Holding History

Ironwood Investment Management’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-14,631
Closed -$236K – 174
2024
Q3 		$236K Buy
+14,631
New +$229K 0.11% 139
2024
Q2 		– Sell
-5,894
Closed -$115K – 179
2024
Q1 		$115K Buy
5,894
+206
+4% +$4.37K 0.06% 166
2023
Q4 		$118K Sell
5,688
-283
-5% -$8.45K 0.06% 156
2023
Q3 		$190K Sell
5,971
-201
-3% -$6.71K 0.12% 145
2023
Q2 		$207K Sell
6,172
-123
-2% -$4.4K 0.12% 147
2023
Q1 		$263K Buy
6,295
+389
+7% +$18.3K 0.16% 133
2022
Q4 		$200K Sell
5,906
-732
-11% -$31.1K 0.13% 144
2022
Q3 		$327K Buy
6,638
+17
+0.3% +$934 0.23% 121
2022
Q2 		$260K Buy
6,621
+3
+0% +$89 0.17% 131
2022
Q1 		$244K Buy
6,618
+194
+3% +$12.1K 0.13% 147
2021
Q4 		$628K Buy
6,424
+7
+0.1% +$753 0.31% 104
2021
Q3 		$801K Buy
6,417
+16
+0.2% +$1.93K 0.42% 84
2021
Q2 		$803K Sell
6,401
-151
-2% -$18K 0.41% 89
2021
Q1 		$889K Buy
6,552
+60
+0.9% +$7.45K 0.47% 75
2020
Q4 		$590K Sell
6,492
-179
-3% -$15.5K 0.35% 97
2020
Q3 		$496K Sell
6,671
-15
-0.2% -$1.15K 0.35% 101
2020
Q2 		$570K Buy
6,686
+3,923
+142% +$356K 0.44% 89
2020
Q1 		$200K Buy
+2,763
New +$267K 0.2% 131

Other funds holding RNAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Ironwood Investment Management's RNAC Position: Q4 2024 in Review

Ironwood Investment Management sold out of Cartesian Therapeutics (RNAC) in Q4 2024, closing a stake of 14,631 shares — an estimated $236K sold.

Ironwood Investment Management first reported a position in RNAC in Q1 2020 and held it in 18 quarters. The position peaked at $889K in Q1 2021. 68 funds tracked by Wall St. Rank hold RNAC as of Q4 2024.

  • Ironwood Investment Management reported no remaining Cartesian Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Ironwood Investment Management sold 14,631 Cartesian Therapeutics shares in Q4 2024, an estimated $236K.
  • Ironwood Investment Management first reported a position in Cartesian Therapeutics in Q1 2020 and held it in 18 quarters.
  • Ironwood Investment Management's Cartesian Therapeutics position peaked at $889K in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q4 2024.

Based on Ironwood Investment Management's 13F filing for Q4 2024, filed 10 Feb 2025.